Quote Originally Posted by Wise Young View Post

Funding is the obstacle, not the FDA. If it only costs $6 million instead of $600 million to do clinical trials for spinal cord injury, a lot more companies will invest in trials, regardless of the FDA.

Wise, isn't there a realtion between cost and FDA requirements?

In any case, since there are less expensive places to do trials ( still with scientific rigour) let's move there or SCI will never become curable, I think.

Last thing,

I think that comparing clinical trials for acute SCI with trials fror chronic SCI is cofusing considering costs and structure needed.